Xencor (XNCR) Receivables - Other (2016 - 2024)
Xencor (XNCR) reported Receivables - Other of $5.7 million for Q4 2024, up 147.83% year-over-year from $2.3 million in Q1 2024, and up 147.83% quarter-over-quarter from $2.3 million in Q4 2023.
Xencor (XNCR) Receivables - Other (2016 - 2024) Analysis & Trends
Xencor (XNCR) has 9 years of Receivables - Other data on file, last reported at $5.7 million in Q4 2024.
- Receivables - Other for Q4 2024 came in at $5.7 million, up 147.83% year-over-year; the trailing twelve-month figure through Dec 2024 was $5.7 million (up 147.83% YoY), and the FY2024 annual result was $5.7 million, up 147.83% from the prior year.
- Receivables - Other improved to $5.7 million in Q4 2024 per XNCR's latest filing, from $2.3 million in the prior quarter.
- Over five years, Receivables - Other peaked at $12.5 million in Q1 2021 and troughed at -$1.4 million in Q1 2020.
- A 5-year average of $2.7 million and a median of $1.3 million in 2020 frame the typical range for Receivables - Other.
- The sharpest annual moves came in 2020 and 2021: Receivables - Other slumped 244.44% in 2020, then soared 992.86% in 2021.
- A 5-year view of Receivables - Other shows it stood at $1.4 million in 2020, then tumbled by 42.86% to $800000.0 in 2021, then soared by 62.5% to $1.3 million in 2022, then surged by 76.92% to $2.3 million in 2023, then surged by 147.83% to $5.7 million in 2024.
- Business Quant data shows XNCR's Receivables - Other at $5.7 million in Q4 2024, $2.3 million in Q4 2023, and $1.3 million in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Xencor | 953.38 Mn | 878.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 5.70 Mn |
| Dec 31, 2024 | 5.70 Mn |
| Dec 31, 2023 | 2.30 Mn |
| Dec 31, 2023 | 2.30 Mn |
| Dec 31, 2022 | 1.30 Mn |
| Dec 31, 2022 | 1.30 Mn |
| Mar 31, 2022 | 5.00 Mn |
| Mar 31, 2022 | 5.00 Mn |
| Dec 31, 2021 | 800,000.00 |
| Dec 31, 2021 | 800,000.00 |
| Jun 30, 2021 | 500,000.00 |
| Jun 30, 2021 | 500,000.00 |
| Mar 31, 2021 | 12.50 Mn |
| Mar 31, 2021 | 12.50 Mn |
| Dec 31, 2020 | 1.40 Mn |
| Dec 31, 2020 | 1.40 Mn |
| Jun 30, 2020 | -1.30 Mn |
| Jun 30, 2020 | -1.30 Mn |
| Mar 31, 2020 | -1.40 Mn |
| Mar 31, 2020 | -1.40 Mn |